| Using Serum Parathyroid Hormones and Calcium to Improve Prostate Cancer Diagnosis (NCT02397629) | Wake Forest University Health Sciences | 2013-05-01 |
| Efficacy,Safety and Quality of Life After TOOKAD® Soluble VTP for Localized Prostate Cancer (NCT01875393) | Steba Biotech S.A. | 2013-05-01 |
| Docetaxel With or Without Low-dose, Short Course Sunitinib in Refractory Solid Tumors (NCT01803503) | National University Hospital, Singapore | 2013-05-01 |
| Focal Therapy for Prostate Cancer - A Pilot Study of Focal Low Dose Rate Brachytherapy (NCT01830166) | British Columbia Cancer Agency | 2013-05-01 |
| Oral Colchicine in Men With Castrate Resistant Prostate Cancer (NCT01481233) | Milton S. Hershey Medical Center | 2013-05-01 |
| Impact of the Geographical FACTor on the Prostate Cancer Stage at Hormonal Therapy Initiation (NCT01729676) | Ferring Pharmaceuticals | 2013-05-01 |
| A Phase II Study of Cabozantinib (XL184) Therapy in Castrate Resistant Prostate Cancer (CRPC) With Visceral Metastases (NCT01834651) | Edwin Posadas, MD | 2013-04-30 |
| Semi-automatic Download of Prostate Biopsy Cores While Keeping the Orientation, Unfolding and Unity of the Sample (NCT01692405) | UC Care, Ltd. | 2013-04-29 |
| A Phase I/IIa Study of UV1 Vaccine in Patients With Prostate Cancer (NCT01784913) | Ultimovacs ASA | 2013-04-15 |
| Feasibility Study of Ultrasound Elastography Detecting Prostate Cancer (NCT03077126) | H. Lee Moffitt Cancer Center and Research Institute | 2013-04-11 |
| Radiation Hypofractionation Via Extended Versus Accelerated Therapy (HEAT) For Prostate Cancer (NCT01794403) | University of Miami | 2013-04-04 |
| A Phase 2 Study to Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension), Administered to Patients With Metastatic Castration-Resistant Prostate Cancer (NCT01812746) | BIND Therapeutics | 2013-04-01 |
| Stereotactic Volumetric Radiotherapy in Prostate Cancer (NCT02423889) | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy | 2013-04-01 |
| Sipuleucel-T and Ipilimumab for Advanced Prostate Cancer (NCT01832870) | Prostate Oncology Specialists, Inc. | 2013-04-01 |
| Evaluation and Predictive Value of Genetic Polymorphisms in the Management of Hormonal Treatment of Prostate Cancer (NCT02440802) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2013-04-01 |
| Open Registry Measuring Impact of Genomic Testing on Treatment of Prostate Cancer Patients (NCT01954004) | Myriad Genetic Laboratories, Inc. | 2013-04-01 |
| Shorter Duration Radiotherapy to Treat Prostate Cancer After Removal of the Prostate (NCT01868386) | Timothy Showalter, MD | 2013-04-01 |
| A Clinical Trial of AdNRGM Plus CB1954 in Prostate Cancer (NCT04374240) | University of Birmingham | 2013-03-19 |
| Best Systemic Therapy or Best Systemic Therapy (BST) Plus Definitive Treatment (Radiation or Surgery) (NCT01751438) | M.D. Anderson Cancer Center | 2013-03-18 |
| Focal Therapy Using HIFU for Localised Prostate Cancer (NCT02016040) | Jewish General Hospital | 2013-03-17 |
| Safety Study of MRI-guided Transurethral Ultrasound Ablation of Prostate Tissue to Treat Localized Prostate Cancer (NCT01686958) | Profound Medical Inc. | 2013-03-13 |
| S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer (NCT01809691) | SWOG Cancer Research Network | 2013-03-08 |
| The Role of Highly Selective Androgen Receptor (AR) Targeted Therapy in Men With Biochemically Relapsed Hormone Sensitive Prostate Cancer (NCT01790126) | Aragon Pharmaceuticals, Inc. | 2013-03-04 |
| Proton Therapy for High Risk Prostate Cancer (NCT01811810) | Abramson Cancer Center at Penn Medicine | 2013-03-01 |
| Bioavailability Study of ODM-201 in Subjects With Metastatic Chemotherapy-naive Castration-resistant Prostate Cancer (NCT01784757) | Orion Corporation, Orion Pharma | 2013-03-01 |
| Intra-operative Trans-rectal Ultrasound Guidance for Robot-assisted Radical Prostatectomy (NCT02001597) | University of British Columbia | 2013-03-01 |
| A Feasibility Study Followed By A Randomized Phase II Study Of Yoga For Radiation Therapy Side Effects In Prostate Cancer (NCT02135653) | Abramson Cancer Center at Penn Medicine | 2013-03-01 |
| Radiologically Guided Biopsies of mCRPC (NCT02432001) | University of California, San Francisco | 2013-02-22 |
| A Study of Neoadjuvant TAK-700 and Leuprorelin Acetate Followed by Surgery Versus Surgery Alone (NCT03211052) | Centre of Experimental Medicine | 2013-02-18 |
| Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumor Activity of Ascending Doses of ARN 509 in Combination With Abiraterone Acetate (NCT01792687) | Aragon Pharmaceuticals, Inc. | 2013-02-05 |
| Eradication of Prostate Cancer Using F-989 (NCT01987999) | Optimal Health Research | 2013-02-01 |
| Prospective Randomized Trial Comparing Urinary Diversion After Robot-assisted Radical Prostatectomy (NCT02108431) | St. Antonius Hospital Gronau | 2013-02-01 |
| Prospective Collection of Surplus Surgical Tumor Tissues and Pre-surgical Blood Samples (NCT01792882) | Global BioClinical | 2013-02-01 |
| The ProCaRis Study: Prostate Cancer Risk Assessment in General Practice (NCT01739062) | University of Aarhus | 2013-02-01 |
| Pilot Trial Evaluating Stereotactic Body Radiotherapy With Integrated Boost for Clinically Localized Prostate Cancer (RAD 1203) (NCT01856855) | John Fiveash, MD | 2013-02-01 |
| Focal Therapy for Prostate Cancer (NCT01802307) | University of Maryland, Baltimore | 2013-02-01 |
| Prospective Multicentre Cohort Study PROREPAIR-B (mCRPC) (NCT03075735) | Centro Nacional de Investigaciones Oncologicas CARLOS III | 2013-01-15 |
| LDR Brachytherapy Versus SBRT for Low and Intermediate Risk Prostate Cancer Patients (NCT02895854) | Kuopio University Hospital | 2013-01-08 |
| Vitamin D3 Supplementation for Low-Risk Prostate Cancer: A Randomized Trial (NCT01759771) | VA Office of Research and Development | 2013-01-03 |
| Immune Responses in Prostate, Lung, Melanoma and Breast Cancer Patients Following Stereotactic Body Radiotherapy (SBRT), Intensity Modulated Radiotherapy (IMRT) or Brachytherapy (NCT01777802) | Mayo Clinic | 2013-01-02 |
| Magnetic Resonance Spectroscopic Imaging Study of Prostatic Fats to Distinguish the Difference Between High and Low Risk Prostate Cancer (NCT01780701) | OHSU Knight Cancer Institute | 2013-01-01 |
| Prostate Cancer Active Surveillance Metformin Trial (NCT01733836) | University Health Network, Toronto | 2013-01-01 |
| Continuous Monitoring of Prostate Position During Radiotherapy (NCT01742403) | Royal North Shore Hospital | 2013-01-01 |
| Induction and Maintenance of Castration After Subcutaneous Injections of Triptorelin Pamoate in Patients With Prostate Cancer (NCT01715129) | Ipsen | 2013-01-01 |
| Study of Dasatinib, Androgen Deprivation Therapy and Radiation (NCT01826838) | Brown University | 2013-01-01 |
| Multi-site Decision Impact Study for Decipher (NCT02034825) | GenomeDx Biosciences Corp | 2013-01-01 |
| Autologous Natural Killer T Cells Infusion for the Treatment of Cancer (NCT01801852) | Chinese PLA General Hospital | 2013-01-01 |
| Red Yeast Rice in Subjects With Clinically Localized Prostate Cancer Undergoing Active Surveillance (NCT01687049) | Dr. Laurence Klotz | 2013-01-01 |
| Cabazitaxel and Radiation For Patients With Prostate Cancer (NCT01650285) | Brown University | 2013-01-01 |
| Pantoprazole and Docetaxel for Men With Metastatic Castration-Resistant Prostate Cancer (NCT01748500) | University Health Network, Toronto | 2013-01-01 |
| One Month Degarelix/Comparator Treatment for Prostate Cancer in Chinese Population (NCT01744366) | Ferring Pharmaceuticals | 2013-01-01 |
| Prostate Cancer Parameters for Patients Receiving Proton Treatment (NCT02110849) | Indiana University | 2013-01-01 |
| Choline-PET for Evaluating the Incidence of Nodal Metastases Among Newly Diagnosed Patients of Prostate Cancer (NCT01769950) | Bangalore Institute of Oncology | 2013-01-01 |
| Study of 89Zr-DFO-MSTP2109A in Patients With Prostate Cancer (NCT01774071) | Memorial Sloan Kettering Cancer Center | 2013-01-01 |
| 3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical Prostatectomy (NCT01751451) | Memorial Sloan Kettering Cancer Center | 2012-12-18 |
| Reolysin Combined With Docetaxel and Prednisone or Docetaxel and Prednisone Alone in Metastatic Castration Resistant Prostate Cancer (NCT01619813) | Canadian Cancer Trials Group | 2012-12-14 |
| PSA Antibody Levels in Samples From Patients With Prostate Cancer Treated on Protocol ECOG-E9802 (NCT01672905) | Eastern Cooperative Oncology Group | 2012-12-07 |
| Health Interventions in Men Undergoing Radical Prostatectomy (NCT01748110) | Johns Hopkins University | 2012-12-01 |
| Prevalence of Neglected Side Effects to Radical Prostatectomy (NCT01742962) | Copenhagen University Hospital at Herlev | 2012-12-01 |
| OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone (NCT01681433) | Costantine Albany | 2012-12-01 |
| Abiraterone Acetate Trial in African American Prostate Cancer Patients (NCT01735396) | Icahn School of Medicine at Mount Sinai | 2012-12-01 |
| Quality of Life in Patients With Clinically Localized Prostate Cancer Treated With Radiosurgery (NCT01766492) | Georgetown University | 2012-12-01 |
| PROstate Cancer Imaging, Treatment and Toxicity (PROCITT) (NCT01418040) | Calvary Mater Newcastle, Australia | 2012-11-28 |
| MRI for Assessing Prostate Cancer Response (NCT01607008) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2012-11-16 |
| The Use of Thermal Suits as Preventing Hypothermia During Surgery (NCT01571544) | Tampere University Hospital | 2012-11-01 |
| Efficacy Study Evaluating Chemotherapy in Prostate Cancer (NCT01978873) | Örebro University, Sweden | 2012-11-01 |
| BKM120+Abiraterone Acetate for Metastatic CRPC (NCT01741753) | Dana-Farber Cancer Institute | 2012-11-01 |
| Choline PET/CT and MRI for Targeted Prostate Biopsy (NCT01751737) | University of Michigan | 2012-11-01 |
| Relative Bioavailability Study of Enzalutamide in Prostate Cancer Patients (NCT01902251) | Astellas Pharma Europe B.V. | 2012-11-01 |
| Impact of a Printed Decision Aid on Patients' Intent to Undertake Prostate Cancer Screening (NCT02156869) | University Paris 7 - Denis Diderot | 2012-11-01 |
| High-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer (NCT01655836) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2012-10-04 |
| A Couple Support Intervention for Prostate Cancer (NCT01842438) | University of Stirling | 2012-10-01 |
| Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T (NCT01727154) | Dendreon | 2012-10-01 |
| Clinical Study Evaluating Targeted Biopsies and Cytological Imprints in Prostate Cancer (NCT01745718) | Oslo University Hospital | 2012-10-01 |
| Prostate Delineation: High Quality Volume CT (NCT01878773) | University Health Network, Toronto | 2012-10-01 |
| Mild Cognitive Impairment in Men Following Androgen Deprivation (NCT01691976) | Imperial College London | 2012-10-01 |
| Safety Study of Pelvic and Prostatic SIB-IMRT With Long-term Androgen Deprivation for High Risk Localized Prostate Cancer (NCT01704027) | Centre Georges Francois Leclerc | 2012-10-01 |
| Study of Everolimus Added to Combined Hormonal and Radiation Therapy for High Risk Prostate Cancer (NCT01642732) | University of Michigan Rogel Cancer Center | 2012-10-01 |
| Evaluation of Four Treatment Modalities in Prostate Cancer With Low or "Early Intermediate" Risk (NCT01717677) | Association of Urologic Oncology (AUO) | 2012-10-01 |
| Assessment of HIFU-induced Prostate Necrosis With Shear-wave Ultrasound Elastography (NCT01729442) | Hospices Civils de Lyon | 2012-10-01 |
| Group-based or Individual Information About Disease and Treatment Plan (NCT01699672) | Norwegian University of Science and Technology | 2012-10-01 |
| Adaptation of the American Cancer Society (ACS) Early Detection of Prostate Cancer Patient Decision Aid for Spanish Speaking Men (NCT01447186) | M.D. Anderson Cancer Center | 2012-09-21 |
| Evaluation of Prostate-specific Membrane Antigen (PSMA)-Based PET Imaging of Primary Prostate Cancer (NCT01496157) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2012-09-11 |
| A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC) (NCT01695044) | Progenics Pharmaceuticals, Inc. | 2012-09-01 |
| FACBC Outcomes for Post Prostatectomy (NCT01666808) | Emory University | 2012-09-01 |
| Imaging During Surgery in Diagnosing Patients With Prostate, Bladder, or Kidney Cancer (NCT01688414) | Stanford University | 2012-09-01 |
| Improving Energy Balance in Men With Prostate Cancer (NCT01886677) | University of Alabama at Birmingham | 2012-09-01 |
| Understanding and Discouraging Overuse of Potentially Harmful Screening Tests (NCT01694784) | University of North Carolina, Chapel Hill | 2012-09-01 |
| Quantification of Respiratory-induced Prostate Motion (NCT00980993) | Oregon Health and Science University | 2012-09-01 |
| Multiparametric MRI for Prostate Cancer Localization and Characterization: New Methods (NCT01761812) | Sunnybrook Health Sciences Centre | 2012-09-01 |
| Combining Ipilimumab With Abiraterone Acetate Plus Prednisone in Chemotherapy and Immunotherapy-naïve Patients With Progressive Metastatic Castration-resistant Prostate Cancer (NCT01688492) | Memorial Sloan Kettering Cancer Center | 2012-09-01 |
| A Study of HSP90 Inhibitor AT13387 Alone or in Combination With Abiraterone Acetate (NCT01685268) | Astex Pharmaceuticals, Inc. | 2012-09-01 |
| Orteronel Maintenance Therapy in Patients With Metastatic Castration Resistant Prostate Cancer and Non-progressive Disease After First-line Docetaxel Therapy (NCT01707966) | Swiss Cancer Institute | 2012-09-01 |
| Studying Repeated DCE-MRI and DWI in Patients Diagnosed With Prostate Cancer (NCT01562223) | American College of Radiology Imaging Network | 2012-08-27 |
| Robotic Assisted Laparoscopic Prostatectomy With or Without Pelvic Drain Placement in Reducing Adverse Events After Surgery in Patients With Prostate Cancer (NCT01613651) | City of Hope Medical Center | 2012-08-24 |
| Study in Japan and Ex-Japan to Characterize the Pharmacokinetic and Pharmacodynamic Response to Orteronel (TAK-700) in Chemotherapy-Naive Participants With Castration-Resistant Prostate Cancer (NCT01666314) | Millennium Pharmaceuticals, Inc. | 2012-08-20 |
| Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer (NCT01615120) | GTx | 2012-08-14 |
| Prostate Advances in Comparative Evidence (NCT01584258) | Royal Marsden NHS Foundation Trust | 2012-08-07 |
| Shared Decision Making in Low Risk Prostate Cancer (NCT01673581) | Massachusetts General Hospital | 2012-08-01 |
| Degarelix Neo-Adjuvant Radical Prostatectomy Trial (NCT01674270) | University Health Network, Toronto | 2012-08-01 |